We are live on ! Find out more
CMBA

C.M. Bidwell & Associates Portfolio holdings

AUM $245M
1-Year Est. Return 23.8%
This Fund
S&P 500
This Quarter Est. Return
+0.84%
1 Year Est. Return
+23.8%
3 Year Est. Return
+70.62%
5 Year Est. Return
+83.19%
10 Year Est. Return
+679.91%
AUM
$165M
AUM Growth
+$994K
Cap. Flow
+$1.37M
Cap. Flow %
0.83%
Top 10 Hldgs %
38.18%
Holding
544
New
44
Increased
65
Reduced
121
Closed
59

Sector Composition

Rank Sector Weight
1 Technology 6.4%
2 Financials 3.15%
3 Consumer Discretionary 2.92%
4 Communication Services 2.86%
5 Healthcare 2.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CGEN icon
451
Compugen
CGEN
$227M
$548 ﹤0.01%
358
DLB icon
452
Dolby
DLB
$5.75B
$547 ﹤0.01%
7
+1
+17% +$76
PDLB icon
453
Ponce Financial Group
PDLB
$494M
$546 ﹤0.01%
42
FLXS icon
454
Flexsteel Industries
FLXS
$307M
$543 ﹤0.01%
+10
New +$550
RSKD icon
455
Riskified
RSKD
$705M
$534 ﹤0.01%
113
+34
+43% +$158
PK icon
456
Park Hotels & Resorts
PK
$2.89B
$507 ﹤0.01%
36
-3,395
-99% -$49.8K
KTOS icon
457
Kratos Defense & Security Solutions
KTOS
$12B
$501 ﹤0.01%
19
SEIC icon
458
SEI Investments
SEIC
$12.6B
$495 ﹤0.01%
6
GOGO icon
459
Gogo Inc
GOGO
$392M
$493 ﹤0.01%
61
TGI
460
DELISTED
Triumph Group
TGI
$466 ﹤0.01%
+25
New +$415
PRA
461
DELISTED
ProAssurance
PRA
$461 ﹤0.01%
29
KRUS icon
462
Kura Sushi USA
KRUS
$600M
$453 ﹤0.01%
+5
New +$468
ASIX icon
463
AdvanSix
ASIX
$452M
$427 ﹤0.01%
15
CTBI icon
464
Community Trust Bancorp
CTBI
$1.42B
$424 ﹤0.01%
+8
New +$438
MAIN icon
465
Main Street Capital
MAIN
$5.52B
$410 ﹤0.01%
7
STRA icon
466
Strategic Education
STRA
$1.81B
$374 ﹤0.01%
4
MTLS
467
Materialise
MTLS
$398M
$373 ﹤0.01%
53
BEAM icon
468
Beam Therapeutics
BEAM
$2.77B
$372 ﹤0.01%
15
NYT icon
469
New York Times
NYT
$10.3B
$364 ﹤0.01%
7
PATH icon
470
UiPath
PATH
$8.14B
$356 ﹤0.01%
28
-174
-86% -$2.3K
SSYS icon
471
Stratasys
SSYS
$782M
$356 ﹤0.01%
40
XENE icon
472
Xenon Pharmaceuticals
XENE
$6.11B
$353 ﹤0.01%
9
ENOV icon
473
Enovis
ENOV
$1.42B
$351 ﹤0.01%
8
CDNA icon
474
CareDx
CDNA
$2.44B
$321 ﹤0.01%
15
CERS icon
475
Cerus
CERS
$516M
$296 ﹤0.01%
192

Similar funds

C.M. Bidwell & Associates's Q4 2024 Portfolio in Review

As of Q4 2024, C.M. Bidwell & Associates held 544 positions worth $165M, up 0.61% from $164M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

C.M. Bidwell & Associates's Q4 2024 filing shows 44 new, 65 increased, 121 reduced and 59 closed positions. Its largest new stake was Gilead Sciences: 3,801 shares worth $351K. The largest sale was Schwab US TIPS ETF, an estimated $556K.

By sector, the portfolio is most concentrated in Technology at 6.4% of assets, up from 6.4% a quarter earlier, followed by Financials and Consumer Discretionary.

  • C.M. Bidwell & Associates's largest Q4 2024 buy was Gilead Sciences: 3,801 shares worth $351K.
  • C.M. Bidwell & Associates added most to Vanguard Short-Term Bond ETF in Q4 2024, an estimated $724K increase.
  • C.M. Bidwell & Associates's biggest Q4 2024 reduction was Schwab US TIPS ETF, cutting an estimated $556K.
  • C.M. Bidwell & Associates fully exited Eli Lilly in Q4 2024, selling an estimated $341K.
  • C.M. Bidwell & Associates's ten largest holdings make up 38% of its $165M portfolio in Q4 2024.
  • C.M. Bidwell & Associates opened 44 new positions and closed 59 in Q4 2024.
  • C.M. Bidwell & Associates's portfolio value rose 0.61% quarter-over-quarter to $165M.

Based on C.M. Bidwell & Associates's 13F filing for Q4 2024, filed 12 Feb 2025.